Page last updated: 2024-11-05

benzenesulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzenesulfonic acid, also known as phenylsulfonic acid, is an organic compound with the formula C6H5SO3H. It is a colorless, hygroscopic, crystalline solid that is very soluble in water. Benzenesulfonic acid is a strong acid, and it is used as a catalyst in many industrial processes. It is also used in the production of dyes, pharmaceuticals, and other chemicals. Benzenesulfonic acid is synthesized by the sulfonation of benzene with concentrated sulfuric acid. This reaction is an electrophilic aromatic substitution, and it is typically carried out at high temperatures. Benzenesulfonic acid can have various effects depending on the application. It can be used as a catalyst, a reagent, or an intermediate in the synthesis of other chemicals. Benzenesulfonic acid is important in the chemical industry as a precursor to other chemicals, such as sodium benzenesulfonate, which is used as a detergent. Benzenesulfonic acid is studied to understand its reactivity and to develop new applications for it. It is also studied to understand the mechanism of the sulfonation reaction.'

benzenesulfonic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

benzenesulfonic acid : The simplest member of the class of a benzenesulfonic acids that consists of a benzene carrying a single sulfo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7371
CHEMBL ID1422641
CHEBI ID64455
SCHEMBL ID2509
MeSH IDM0101058

Synonyms (70)

Synonym
benzenemonosulfonic acid
98-11-3
benzenesulfonic acid
inchi=1/c6h6o3s/c7-10(8,9)6-4-2-1-3-5-6/h1-5h,(h,7,8,9
benzene sulfonic acid
NCGC00091687-01
hsdb 2642
benzenesulphonic acid
ccris 4595
phenylsulfonic acid
brn 0742513
ai3-15297
benzene sulphonic acid
einecs 202-638-7
besylic acid
kyselina benzensulfonova [czech]
17-120a
benzenesulfonic acid, technical grade, 90%
benzenesulfonic acid, 98.0% (t)
B0030
B3408
A845812
NCGC00091687-02
benzolsulfonsäure
cas-98-11-3
tox21_303131
dtxsid9024568 ,
dtxcid404568
NCGC00256989-01
tox21_201960
NCGC00259509-01
STL280343
CHEBI:64455 ,
blu-gard snitizing teat dip
ec 202-638-7
4-11-00-00027 (beilstein handbook reference)
kyselina benzensulfonova
685928z18a ,
unii-685928z18a
FT-0622648
AKOS015856636
benzensulfonic acid
benzenesulfonic acid [mi]
benzenesulfonic acid [hsdb]
benzenesulfonic acid [ii]
SCHEMBL2509
benzenesulphonicacid
ph-so3h
CHEMBL1422641
STR07703
mfcd00011689
J-519685
SR-01000944759-1
sr-01000944759
benzenesulfonic acid, technical, >=90% (t)
CS-D1398
Q421494
AMY20768
phenylsulfonic acid;besylic acid;kyselina benzensulfonova
BCP30635
phenyl sulfonic acid
D89012
p-toluenesulfonic acid, polymer bound (mp-tsoh), loading: 3-7 mmol/g, poly(stryene-co-dvb) resin, 30 - 60 mesh
benzenesulfonic acid, (benzene < 2 ppm)
PB48035
benezenesulfonate
STARBLD0034875
EN300-84101
benzenesulfonic acid (surfactant)
benzenesulfonic acid (ii)

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Replacement of the lone amide bond with two methylene groups in this series yields more lipophilic compounds that have longer half-lives, lower clearance, and greater oral bioavailability when administered to dogs."( Nonpeptide alpha V beta 3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backbone.
Askew, BC; Duggan, ME; Duong, LT; Fernandez-Metzler, C; Halczenko, W; Hartman, GD; Hutchinson, JH; Leu, CT; Prueksaritanont, T; Rodan, GA; Rodan, SB; Whitman, DB, 2004
)
0.32
" The aim of this study was to prepare two sulfonate salts of cilostazol to increase the dissolution and hence the oral bioavailability of cilostazol."( Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate.
Bae, SK; Choi, WK; Oh, E; Park, JB; Park, S; Seo, JH; Sung, YJ, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
" The cholesterol removal and all the agents used induced dose-response decreases in membrane lipid order as measured by fluorescence polarization or ESR."( The effects of membrane lipid order and cholesterol on the internal and external cationic sites of the Na+-K+ pump in erythrocytes.
Bruckdorfer, KR; Chailley, B; Claret, M; Giraud, F, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenesulfonic acidsAn arenesulfonic acid that consists of a benzene ring substituted by at least one sulphonic acid group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency0.12590.000221.22318,912.5098AID588516
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency60.94410.003041.611522,387.1992AID1159555
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency21.81350.023723.228263.5986AID743223
Histone H2A.xCricetulus griseus (Chinese hamster)Potency126.48400.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.02000.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency61.89650.000627.21521,122.0200AID743202; AID743219
survival motor neuron protein isoform dHomo sapiens (human)Potency11.22020.125912.234435.4813AID1458
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency39.81070.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (12.79)18.7374
1990's8 (9.30)18.2507
2000's24 (27.91)29.6817
2010's30 (34.88)24.3611
2020's13 (15.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 96.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index96.01 (24.57)
Research Supply Index4.49 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index170.16 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (96.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other88 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]